Efficacy of Filgotinib, a Selective jak1 Inhibitor, is Independent of Prior Anti-TNF Exposure: Subgroup Analysis of the Phase 2 Fitzroy Study in Moderate-To-Severe Crohn’s Disease - D'Haens, Geert R; Schreiber, Stefan; Petryka, Robert; Kuehbacher, Tanja; Hebuterne, Xavier; Roblin, Xavier; Klopocka, Maria; Goldis, Adrian; Wisniewska-Jarosinska, Maria A; Baranovsky, Andrei; Sike, Robert; Stoyanova, Kremena; et al. (Gastroenterology (New York, N.Y. 1943), 2017)
Keywords: Gastroenterology and Hepatology